AzTrials
AzTrials

Post-Exercise HypotensionNCT06702930

Exercise Timing on the Morning Blood Pressure Surge

A study testing Morning high-intensity interval exercise and Evening high-intensity interval exercise in people with Post-Exercise Hypotension and Ambulatory Blood Pressure Monitoring, run by University of Guelph at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial was to assess the effects of morning vs. evening high-intensity interval exercise on the magnitude of the morning blood pressure surge in young healthy adults. Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
What is being tested?
Morning high-intensity interval exercise and Evening high-intensity interval exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
1 siteCanada
Study dates
28 Jan 2020to 8 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Between 18-50 years of age.
  • No history of known disease.
  • None smokers.
  • No use of chronic medications other than oral contraceptives.

Who cannot join

  • <18 years of age.
  • >50 years of age.
  • Cardiovascular disease.
  • Metabolic disease.
  • History of smoking (within the past 3 months).
  • Chronic medications (other than oral contraceptives).

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of Guelph

    Guelph, Ontario, N1G 2W1

Other trials in Canada

About this study

Official title: The Effects of Morning vs. Evening High-intensity Interval Exercise on the Magnitude of the Morning Blood Pressure Surge

The goal of this clinical trial was to assess the effects of morning vs. evening high-intensity interval exercise on the magnitude of the morning blood pressure surge in young healthy adults. The main questions it aimed to answer were:

  • Does the timing of high-intensity interval exercise modulate the magnitude of the morning blood pressure surge?
  • Do sex differences exist?

Participants came in and completed a bout of high-intensity interval exercise in the morning (8-10 am) and evening (5-7 pm) as well as a no exercise control, and ambulatory blood pressure was assessed for 24 hours afterwards.

Read the detailed description

Introductory Visit:

Participants came in for 4 visits. The first visit was an introductory visit where chronotype, eligibility for exercise, and anthropometrics were measured. This was followed by a maximal incremental exercise test to determine aerobic capacity (i.e., V̇O2peak) on a cycle ergometer, and instrumentation of an ambulatory blood pressure monitor for familiarization during daily activities and sleep.

Intervention Visits:

Three intervention visits (control, morning exercise, and evening exercise) were completed. The order was randomized using and each visit was separated by a minimum of 36 hours. Each intervention visit began by obtaining the participant's resting blood pressure and heart rate and ended with the instrumentation of the ambulatory blood pressure monitor. No exercise was performed during the control visit. The morning exercise visit included a bout of high-intensity interval exercise between 8-10 am and the evening exercise visit included a bout of high-intensity interval exercise between 5-7 pm. The high-intensity interval exercise protocol consisted of a light intensity, 3-minute warm-up at 15% peak power followed by ten 1-minute work intervals at 80% of peak power, with each interval separated by 1-minute rest intervals at 15% peak power. A 3-minute cool down was performed at 15% peak power.

Being tested
Morning high-intensity interval exercise, Evening high-intensity interval exercise
Keywords
Ambulatory blood pressure monitoring, Morning blood pressure surge, High-intensity interval exercise, Post-exercise hypotension
Medical subject headings
Post-Exercise Hypotension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Morning high-intensity interval exerciseOther

    High-intensity interval exercise was performed between 8-10 am

  • Evening high-intensity interval exerciseOther

    High-intensity interval exercise was performed between 5-7 pm

Study groups in NCT06702930
Study groupRoleWhat they receive
ControlNo interventionNo exercise was performed and ambulatory blood pressure was assessed for 24 hours.
Morning high-intensity interval exerciseExperimentalHigh-intensity interval exercise was performed between 8-10 am and ambulatory blood pressure was assessed for 24 hours after.
Receives: Other: Morning high-intensity interval exercise
Evening high-intensity interval exerciseExperimentalHigh-intensity interval exercise was performed between 5-7 pm and ambulatory blood pressure was assessed for 24 hours after.
Receives: Other: Evening high-intensity interval exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Morning blood pressure surge

    The difference between morning blood pressure (the mean of the 4 blood pressure readings after awakening) and sleep-trough blood pressure (the mean of the lowest blood pressure during sleep and two adjacent blood pressure readings).

    Measured: Through study completion, an average of 4 weeks.

Secondary outcomes (1)
  1. Nighttime blood pressure dip

    The percent difference between daytime blood pressure (average of all blood pressure readings when participants reported being awake) and nighttime blood pressure (average of all blood pressure readings when the participant reported being asleep).

    Measured: Through study completion, an average of 4 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Nov 2024
  2. Study start28 Jan 2020
  3. Primary completion8 Jun 2023
  4. Study completion8 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06702930
Sponsor's protocol ID
19-07-002
Status last verified
Nov 2024
First submitted
19 Nov 2024
Last updated
27 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

Publications

  • Bommarito J, Millar PJ. The effects of morning versus evening high-intensity interval exercise on the magnitude of the morning blood pressure surge. Appl Physiol Nutr Metab. 2025 Jan 1;50:1-11. doi: 10.1139/apnm-2024-0449.

    PubMed 39689295

Questions about this trial

What is this clinical trial studying?

A study testing Morning high-intensity interval exercise and Evening high-intensity interval exercise in people with Post-Exercise Hypotension and Ambulatory Blood Pressure Monitoring, run by University of Guelph at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Morning blood pressure surge (time frame: Through study completion, an average of 4 weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06702930, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in